CDK1 antibody (C-Term) (FITC)
Quick Overview for CDK1 antibody (C-Term) (FITC) (ABIN4880075)
Target
See all CDK1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- C-Term
-
Specificity
- This antibody recognises cyclin-dependent kinase 1 (Cdk1), a 34 kDa protein kinase which is also known as Cdc2. Cdk1 is a serine/threonine kinase which forms complexes with cyclins A and B which then phosphorylate a variety of target substrates to enable cell cycle progression.
-
Purification
- Purified on protein A from tissue culture supernatant.
-
Immunogen
- C-terminal fragment starting at amino acid 85 of Xenopus laevis p34 cdc2
-
Isotype
- IgG2a
-
-
-
-
Application Notes
- Optimal antibody dilution should be determined by titration
-
Comment
-
Myeloma, fusion partners: Cells from immunized Balb/c mice were fused with the Sp2/0-Ag.14 myeloma cell line
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Purified IgG conjugated to Fluoroscein using Innova Biosciences Lightning-Link®, supplied in Phosphate buffered saline (PBS) containing 0.02 % Sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- CDK1 (Cyclin-Dependent Kinase 1 (CDK1))
-
Alternative Name
- CDK1
-
OMIM
- 116940
-
Pathways
- Cell Division Cycle, Fc-epsilon Receptor Signaling Pathway, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Mitotic G1-G1/S Phases, DNA Replication, M Phase, Toll-Like Receptors Cascades, Synthesis of DNA
Target
-